Status:
COMPLETED
Motor Unit Abnormalities After Experimentally Induced Sensitization
Lead Sponsor:
Toronto Rehabilitation Institute
Conditions:
Central Sensitisation
Motor Disorders
Eligibility:
All Genders
20-70 years
Phase:
PHASE4
Brief Summary
Central sensitization is a condition that represents a cascade of neurological adaptations, resulting in an amplification of nociceptive responses from noxious and non-noxious stimuli. This phenomenon...
Detailed Description
Central sensitization describes a state of neuronal hyper-excitability in the central nervous system that may occur due to malfunction of spinal and supraspinal pain facilitatory and inhibitory circui...
Eligibility Criteria
Inclusion
- subject with a normal body mass index (18.5 - 24.9)
- a pain visual analogue scale (VAS) below 3 indicating low pain severity
Exclusion
- medical history of inflammatory disorders as rheumatoid arthritis
- neurodegenerative disorders such as Parkinson's disease
- motor neurone diseases as amyotrophic lateral sclerosis, or other neuromuscular disorder
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 10 2020
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04361149
Start Date
October 1 2019
End Date
March 10 2020
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Rehabilitation Institute
Toronto, Ontario, Canada, M5S 1A1